Our Business

Phosphagenics is a Melbourne-based, globally driven biotechnology company focused on the discovery of new and cost effective ways to enhance the delivery of proven pharmaceutical and nutraceutical products.

Phosphagenics' shares are listed on the Australian Stock Exchange (POH) and Phosphagenics' ADR's (PPGNY) are traded on the OTCQX in the US.

Breaking News

8 May 2012

PHOSPHAGENICS ADDS DAVID JONES TO ITS LIST OF GROWING RETAIL PARTNERS

Phosphagenics is pleased to announce the addition of David Jones to its list of growing retail partners. David Jones is Australia’s premier department chain. It has a strong retail reputation in beauty and cosmetics. The Elixia® range of high performance skincare products, together with the best-selling BodyShaper Cellulite Contour Crème®, will be launched throughout selected David Jones stores nationally over the next two months.

Phosphagenics Limited Research Report - Bell Potter Report

Click here for Dr Esra Ogru's Sky News feature (11 Jan 2012)

4 April 2012

PHOSPHAGENICS SIGNS LICENSE AGREEMENT WITH INTAS PHARMACEUTICALS LTD

Phosphagenics is pleased to announce that they have signed a licensing agreement with Intas Pharmaceuticals Ltd, an India based pharmaceuticals company, for the manufacture and sale of three anti-ageing products specifically formulated by Phosphagenics for the Indian market.

Read our latest news: April 2012 NEWSLETTER

AGM:

Thursday, 24 May 2012, commencing at 3 pm at Minter Ellison, Level 23, Rialto Towers, 525 Collins St, Melbourne, Vic.

To view all releases in full please click here